The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 28,333 | 391,719 | SH | SOLE | 391,719 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 45,365 | 492,078 | SH | SOLE | 492,078 | 0 | 0 | ||
ABIOMED, Inc. | Common | 003654100 | 4,014 | 12,350 | SH | SOLE | 12,350 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 1,624 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 00404A109 | 4,452 | 173,155 | SH | SOLE | 173,155 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 7,437 | 170,766 | SH | SOLE | 170,766 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 507 | 318,833 | SH | SOLE | 318,833 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 1,314 | 228,496 | SH | SOLE | 228,496 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 9,734 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 1,400 | 38,770 | SH | SOLE | 38,770 | 0 | 0 | ||
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 1,301 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 790 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 553 | 8,200 | SH | SOLE | 8,200 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 2,261 | 49,025 | SH | SOLE | 49,025 | 0 | 0 | ||
Akebia Therapeutics, Inc. | Common | 00972D105 | 1,183 | 213,942 | SH | SOLE | 213,942 | 0 | 0 | ||
Albireo Pharma, Inc. | Common | 01345P106 | 3,066 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 48,319 | 496,288 | SH | SOLE | 496,288 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 6,254 | 29,860 | SH | SOLE | 29,860 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 4,464 | 151,283 | SH | SOLE | 151,283 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 31,373 | 234,720 | SH | SOLE | 234,720 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621309 | 278 | 148,500 | SH | SOLE | 148,500 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 9,199 | 126,176 | SH | SOLE | 126,176 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 8,902 | 654,052 | SH | SOLE | 654,052 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 8,318 | 111,807 | SH | SOLE | 111,807 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 131,958 | 677,855 | SH | SOLE | 677,855 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 8,385 | 875,304 | SH | SOLE | 875,304 | 0 | 0 | ||
AnaptysBio, Inc. | Common | 032724106 | 4,200 | 65,845 | SH | SOLE | 65,845 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 37,069 | 141,147 | SH | SOLE | 141,147 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 271 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 1,144 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 2,036 | 52,262 | SH | SOLE | 52,262 | 0 | 0 | ||
ArQule, Inc. | Common | 04269E107 | 693 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Array BioPharma Inc. | Common | 04269X105 | 5,189 | 364,166 | SH | SOLE | 364,166 | 0 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 381 | 30,700 | SH | SOLE | 30,700 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 2,656 | 42,399 | SH | SOLE | 42,399 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 16,256 | 428,024 | SH | SOLE | 428,024 | 0 | 0 | ||
Athenex, Inc. | Common | 04685N103 | 578 | 45,530 | SH | SOLE | 45,530 | 0 | 0 | ||
Audentes Therapeutics, Inc. | Common | 05070R104 | 1,121 | 52,574 | SH | SOLE | 52,574 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 2,102 | 814,588 | SH | SOLE | 814,588 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 071734107 | 3,546 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Baxter International Inc. | Common | 071813109 | 10,612 | 161,233 | SH | SOLE | 161,233 | 0 | 0 | ||
Becton, Dickinson and Company | Common | 075887109 | 15,722 | 69,778 | SH | SOLE | 69,778 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 12,028 | 85,755 | SH | SOLE | 85,755 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 175 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 118,834 | 394,902 | SH | SOLE | 394,902 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 17,663 | 207,434 | SH | SOLE | 207,434 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 9,764 | 98,429 | SH | SOLE | 98,429 | 0 | 0 | ||
Blueprint Medicines Corporation | Common | 09627Y109 | 6,750 | 125,207 | SH | SOLE | 125,207 | 0 | 0 | ||
Boston Scientific Corporation | Common | 101137107 | 15,726 | 444,991 | SH | SOLE | 444,991 | 0 | 0 | ||
Bristol-Myers Squibb Company | Common | 110122108 | 33,941 | 652,966 | SH | SOLE | 652,966 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 281 | 6,300 | SH | SOLE | 6,300 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 88,573 | 1,382,006 | SH | SOLE | 1,382,006 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 21 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis SA | Sponsored ADR | 15117K103 | 3,938 | 236,530 | SH | SOLE | 236,530 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 19,240 | 166,869 | SH | SOLE | 166,869 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 2,566 | 22,670 | SH | SOLE | 22,670 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 373 | 158,784 | SH | SOLE | 158,784 | 0 | 0 | ||
Cigna Corporation | Common | 125523100 | 12,172 | 64,089 | SH | SOLE | 64,089 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 177 | 165,330 | SH | SOLE | 165,330 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 1,354 | 75,400 | SH | SOLE | 75,400 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 2,852 | 315,162 | SH | SOLE | 315,162 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 575 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
Concert Pharmaceuticals, Inc. | Common | 206022105 | 569 | 45,362 | SH | SOLE | 45,362 | 0 | 0 | ||
CRISPR Therapeutics AG | Namen AKT | H17182108 | 5,095 | 178,348 | SH | SOLE | 178,348 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 30,185 | 460,698 | SH | SOLE | 460,698 | 0 | 0 | ||
Danaher Corporation | Common | 235851102 | 21,590 | 209,371 | SH | SOLE | 209,371 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 4,675 | 125,625 | SH | SOLE | 125,625 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 1,162 | 161,579 | SH | SOLE | 161,579 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 6,807 | 505,701 | SH | SOLE | 505,701 | 0 | 0 | ||
Dr. Reddy's Laboratories Limited | Common | 256135203 | 1,376 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
Editas Medicine, Inc. | Common | 28106W103 | 1,744 | 76,668 | SH | SOLE | 76,668 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 8,700 | 56,798 | SH | SOLE | 56,798 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 700 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eidos Therapeutics, Inc. | Common | 28249H104 | 384 | 27,900 | SH | SOLE | 27,900 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 25,047 | 216,442 | SH | SOLE | 216,442 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 5,236 | 717,274 | SH | SOLE | 717,274 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 2,377 | 385,872 | SH | SOLE | 385,872 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 6,545 | 142,289 | SH | SOLE | 142,289 | 0 | 0 | ||
Evolent Health, Inc. | Common | 30050B101 | 841 | 42,150 | SH | SOLE | 42,150 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 6,677 | 339,435 | SH | SOLE | 339,435 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 9,847 | 212,763 | SH | SOLE | 212,763 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 2,158 | 601,205 | SH | SOLE | 601,205 | 0 | 0 | ||
Galapagos NV | Common | 36315X101 | 9,157 | 99,815 | SH | SOLE | 99,815 | 0 | 0 | ||
Genomic Health, Inc. | Common | 37244C101 | 1,119 | 17,370 | SH | SOLE | 17,370 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 118,210 | 1,889,846 | SH | SOLE | 1,889,846 | 0 | 0 | ||
GlaxoSmithKline plc | Shares | 37733W105 | 8,357 | 218,700 | SH | SOLE | 218,700 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 3,856 | 93,924 | SH | SOLE | 93,924 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 653 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 6,169 | 63,345 | SH | SOLE | 63,345 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 9,251 | 74,335 | SH | SOLE | 74,335 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,271 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Incorporated | Common | 421946104 | 1,934 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,164 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 803 | 19,546 | SH | SOLE | 19,546 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 19,620 | 68,487 | SH | SOLE | 68,487 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 9,594 | 51,575 | SH | SOLE | 51,575 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 78,695 | 262,379 | SH | SOLE | 262,379 | 0 | 0 | ||
ImmunoGen, Inc. | Common | 45253H101 | 807 | 168,190 | SH | SOLE | 168,190 | 0 | 0 | ||
Immunomedics, Inc. | Common | 452907108 | 6,158 | 431,527 | SH | SOLE | 431,527 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 41,044 | 645,442 | SH | SOLE | 645,442 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 2,820 | 161,603 | SH | SOLE | 161,603 | 0 | 0 | ||
Inogen, Inc. | Common | 45780L104 | 1,676 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | ||
Inovalon Holdings, Inc. | Common | 45781D101 | 2,498 | 176,163 | SH | SOLE | 176,163 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 2,051 | 150,290 | SH | SOLE | 150,290 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 1,345 | 13,348 | SH | SOLE | 13,348 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 1,255 | 110,193 | SH | SOLE | 110,193 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 18,788 | 39,229 | SH | SOLE | 39,229 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 4,478 | 82,838 | SH | SOLE | 82,838 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 1,920 | 216,908 | SH | SOLE | 216,908 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 4,542 | 39,100 | SH | SOLE | 39,100 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 14,279 | 115,187 | SH | SOLE | 115,187 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 133,261 | 1,032,628 | SH | SOLE | 1,032,628 | 0 | 0 | ||
Jounce Therapeutics, Inc. | Common | 481116101 | 34 | 10,127 | SH | SOLE | 10,127 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 2,998 | 85,400 | SH | SOLE | 85,400 | 0 | 0 | ||
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 3,677 | 29,100 | SH | SOLE | 29,100 | 0 | 0 | ||
LeMaitre Vascular, Inc. | Common | 525558201 | 642 | 27,150 | SH | SOLE | 27,150 | 0 | 0 | ||
Lexicon Pharmaceuticals, Inc. | Sponsored ADR | 528872302 | 465 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 3,589 | 26,450 | SH | SOLE | 26,450 | 0 | 0 | ||
LivaNova plc | Shares | G5509L101 | 1,043 | 11,400 | SH | SOLE | 11,400 | 0 | 0 | ||
Loxo Oncology, Inc. | Common | 548862101 | 3,445 | 24,595 | SH | SOLE | 24,595 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 7,445 | 178,623 | SH | SOLE | 178,623 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 752 | 6,670 | SH | SOLE | 6,670 | 0 | 0 | ||
Mallinckrodt plc | Sponsored ADR | G5785G107 | 847 | 53,600 | SH | SOLE | 53,600 | 0 | 0 | ||
Marinus Pharmaceuticals, Inc. | Common | 56854Q101 | 2,169 | 755,776 | SH | SOLE | 755,776 | 0 | 0 | ||
Masimo Corporation | Common | 574795100 | 1,826 | 17,011 | SH | SOLE | 17,011 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 8,696 | 78,720 | SH | SOLE | 78,720 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 6,654 | 413,809 | SH | SOLE | 413,809 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 8,211 | 428,992 | SH | SOLE | 428,992 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 43,785 | 481,365 | SH | SOLE | 481,365 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 56,399 | 738,108 | SH | SOLE | 738,108 | 0 | 0 | ||
Merus N.V. | Common | N5749R100 | 5,147 | 367,671 | SH | SOLE | 367,671 | 0 | 0 | ||
Mettler-Toledo International Inc. | Common | 592688105 | 1,980 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 576 | 13,590 | SH | SOLE | 13,590 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 582 | 144,110 | SH | SOLE | 144,110 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 38,462 | 1,403,728 | SH | SOLE | 1,403,728 | 0 | 0 | ||
MyoKardia, Inc. | Common | 62857M105 | 1,886 | 38,600 | SH | SOLE | 38,600 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 3,102 | 94,384 | SH | SOLE | 94,384 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 15,446 | 216,294 | SH | SOLE | 216,294 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 2,674 | 68,760 | SH | SOLE | 68,760 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 1,297 | 314,747 | SH | SOLE | 314,747 | 0 | 0 | ||
Nightstar Therapeutics plc | ADR | 65413A101 | 1,140 | 98,929 | SH | SOLE | 98,929 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 25,032 | 291,717 | SH | SOLE | 291,717 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 1,051 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | ADR | 670100205 | 13,909 | 301,900 | SH | SOLE | 301,900 | 0 | 0 | ||
Novocure Limited | Ordinary Shares | G6674U108 | 820 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
NuCana plc | Sponsored ADR | 67022C106 | 142 | 9,823 | SH | SOLE | 9,823 | 0 | 0 | ||
NuVasive, Inc. | Common | 670704105 | 1,428 | 28,816 | SH | SOLE | 28,816 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 13,361 | 380,122 | SH | SOLE | 380,122 | 0 | 0 | ||
Ovid Therapeutics Inc. | ADR | 690469101 | 1,203 | 496,977 | SH | SOLE | 496,977 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 1,445 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 66,208 | 1,516,793 | SH | SOLE | 1,516,793 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 6,268 | 391,016 | SH | SOLE | 391,016 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 5,552 | 2,087,380 | SH | SOLE | 2,087,380 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 2,254 | 115,448 | SH | SOLE | 115,448 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 6,480 | 70,460 | SH | SOLE | 70,460 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,327 | 197,138 | SH | SOLE | 197,138 | 0 | 0 | ||
PTC Therapeutics, Inc. | Common | 69366J200 | 2,356 | 68,652 | SH | SOLE | 68,652 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 1,696 | 83,340 | SH | SOLE | 83,340 | 0 | 0 | ||
Quest Diagnostics Incorporated | Common | 74834L100 | 5,537 | 66,500 | SH | SOLE | 66,500 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 69 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 50,954 | 136,422 | SH | SOLE | 136,422 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 6,676 | 58,630 | SH | SOLE | 58,630 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | Common | 76243J105 | 669 | 24,890 | SH | SOLE | 24,890 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 8,946 | 542,862 | SH | SOLE | 542,862 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 9,430 | 98,444 | SH | SOLE | 98,444 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | Common | 800677106 | 2,773 | 241,538 | SH | SOLE | 241,538 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 7,809 | 179,900 | SH | SOLE | 179,900 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 20,935 | 191,837 | SH | SOLE | 191,837 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 12,819 | 226,239 | SH | SOLE | 226,239 | 0 | 0 | ||
Senior Housing Properties Trust | Common | 81721M109 | 4,421 | 377,220 | SH | SOLE | 377,220 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 6,303 | 36,216 | SH | SOLE | 36,216 | 0 | 0 | ||
Smith & Nephew plc | Shares | 83175M205 | 6,933 | 185,478 | SH | SOLE | 185,478 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 422 | 10,772 | SH | SOLE | 10,772 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 10,362 | 144,424 | SH | SOLE | 144,424 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 1,003 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G84720104 | 5,129 | 48,003 | SH | SOLE | 48,003 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 25,148 | 160,432 | SH | SOLE | 160,432 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 2,074 | 229,900 | SH | SOLE | 229,900 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 890 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Takeda Pharmaceutical Co. Ltd. | Sponsored ADS | 687044008 | 649 | 19,200 | SH | SOLE | 19,200 | 0 | 0 | ||
Teleflex Incorporated | Common | 879369106 | 1,649 | 6,379 | SH | SOLE | 6,379 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 2,419 | 141,136 | SH | SOLE | 141,136 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 971 | 859,322 | SH | SOLE | 859,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 18,687 | 1,211,868 | SH | SOLE | 1,211,868 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 42,944 | 191,895 | SH | SOLE | 191,895 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 763 | 446,099 | SH | SOLE | 446,099 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 3,346 | 76,958 | SH | SOLE | 76,958 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 1,088 | 37,741 | SH | SOLE | 37,741 | 0 | 0 | ||
United Therapeutics Corporation | Class B | 91307C102 | 4,493 | 41,261 | SH | SOLE | 41,261 | 0 | 0 | ||
Unitedhealth Group Incorporated | Common | 91324P102 | 93,513 | 375,374 | SH | SOLE | 375,374 | 0 | 0 | ||
Varian Medical Systems, Inc. | Common | 92220P105 | 2,972 | 26,227 | SH | SOLE | 26,227 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 5,771 | 98,496 | SH | SOLE | 98,496 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 2,475 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 70,634 | 426,248 | SH | SOLE | 426,248 | 0 | 0 | ||
Viking Therapeutics, Inc. | Common | 92686J106 | 436 | 57,008 | SH | SOLE | 57,008 | 0 | 0 | ||
Waters Corporation | Common | 941848103 | 2,037 | 10,800 | SH | SOLE | 10,800 | 0 | 0 | ||
WellCare Health Plans, Inc. | Common | 94946T106 | 3,069 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 3,162 | 45,560 | SH | SOLE | 45,560 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 3,631 | 133,391 | SH | SOLE | 133,391 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 2,031 | 56,172 | SH | SOLE | 56,172 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,252 | 89,204 | SH | SOLE | 89,204 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 21,506 | 251,415 | SH | SOLE | 251,415 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 4,048 | 111,025 | SH | SOLE | 111,025 | 0 | 0 |